Mauricio Monaco
About Mauricio Monaco
Mauricio Monaco is the Vice President of Medical Data Generation at Bristol Myers Squibb, with extensive experience in oncology and senior roles at Merck, Novartis Oncology, and Pfizer.
Current Role at Bristol Myers Squibb
Mauricio Monaco currently serves as the Vice President of Medical Data Generation at Bristol Myers Squibb in Princeton, New Jersey, United States. In this role, he is responsible for leading initiatives and strategies for generating medical data. His position involves overseeing the collection, analysis, and dissemination of clinical data, supporting the company's objectives to enhance patient outcomes and drive medical innovation.
Experience at Merck
Mauricio Monaco has accumulated significant experience from multiple roles at Merck. From 2020 to 2021, he worked as the Associate Vice President of Pipeline and Precision Medicine (Global Medical Affairs Oncology) in Kenilworth, New Jersey. Before that, he held the position of Executive Director and GU Team Leader in Oncology Global Medical Affairs from 2018 to 2020. Additionally, he briefly served as the International Medical Lead for GU/GI cancers in Oncology Medical Affairs in 2018. His responsibilities included driving global medical strategies and advancing precision medicine initiatives in oncology.
Roles at Novartis Oncology
At Novartis Oncology, Mauricio Monaco held several key positions. He was the Executive Medical Director and Head of US Clinical Strategy for Breast Cancer from 2017 to 2018. Previous roles include Executive Director and Global Brand Medical Director for Ribociclib from 2016 to 2017, and Senior Global Medical Affairs Director for Ribociclib from 2014 to 2016. He also served as the Senior Director Clinical Research Physician for oncology projects involving MEK inhibitors from 2013 to 2014. His leadership was crucial in shaping clinical development plans and global medical strategies.
Tenure at Pfizer
Mauricio Monaco's career at Pfizer spanned multiple roles and regions. From 2011 to 2013, he was the Senior Regional Medical Director for Oncology in New York. Prior to that, he served as the Regional Medical Director for Oncology in Africa, Middle East, and Latin America from 2009 to 2011, and before that, the Regional Medical Director for Canada, Africa, Middle East, and Latin America in 2008-2009. He started at Pfizer as a Product Physician and Group Product Physician, working from 2003 to 2008 in São Paulo, Brazil.
Educational Background
Mauricio Monaco has an extensive educational background in medicine, oncology, and related fields. He earned a Master of Science in Cancer and Clinical Oncology from Queen Mary University of London (Barts Cancer Institute) between 2019 and 2021. He also holds a Master’s Degree in Biotechnology from The Johns Hopkins University, achieved between 2012 and 2015. Earlier, he specialized in Pharmaceutical Medicine at Universidade Federal de São Paulo from 1999 to 2000. He completed his residency in General Pediatrics at Universidade de São Paulo from 1992 to 1993 and received his Doctor of Medicine (M.D.) degree from the same university in 1991.